Matthias Schwab (born September 3, 1963 in Nuremberg) is a German doctor and university lecturer.

After graduating from the Dürer Gymnasium in Nuremberg, Schwab studied Medicine and obtained his doctorate in 1991 at the Institute for Toxicology and Pharmacology at the Friedrich-Alexander University of Erlangen–Nuremberg.

After a visiting professorship at the St. Jude Children’s Research Hospital in Memphis (Tennessee, USA) he took over the management of the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and the Chair of Clinical Pharmacology at the University of Tübingen, where he has also been a co-opted professor of the faculty of mathematical and natural science since 2015.

[2] He is particularly interested in the application of new technologies in the context of pharmacogenomics including epigenetic[3] aspects in connection with cancer therapies[4] and immunosuppressants Appointments as full professor for clinical pharmacology at the Medical University of Innsbruck, Austria (2006), as well as professor and chair of clinical pharmacology with simultaneous position as senior physician in the clinic at Karolinska University and Karolinska University Hospital, Sweden (2010), he declined.

Since 2018 he is Adjunct Professor of the Departments of Clinical Pharmacology and Biochemistry at Yerevan State Medical University, Armenia.